attana - sensor technologies

Attana Awarded Eurostars Program Grant

Attana and partners receive project grant of €500.000 for development of sensitive cell-based biosensors using peptide matrices.

Stockholm, April 18, 2017 – Attana AB, Biogelx Ltd and University of Stuttgart, Institute of Cell Biology and Immunology, Prof. Kontermann’s group has been granted €500.000 from the Eurostars program supporting R&D performing SMEs.

The project aims at developing biologically relevant tools for pre-clinical studies based on Attana's cell-based 3rd generation biosensors, Biogelex's 3D hydrogel matrix for cell growth and Prof. Kontermann’s leading knowledge in biotherapeutics. The tool will increase the success rate and cut the costs for pharmaceutical companies developing new drugs.

The project will adapt Biogelx peptide based 3D hydrogel technology to Attana's sensor chips. The 3D gel-chips will offer a tissue-mimicking environment, ensuring increased biological relevance and high data quality. The new assays will be developed and validated according to the R&D processes used by Prof Kontermann's group.

To learn more about Attana contract research services and our label free cell-based biosensors, please visit www.attana.com or contact our sales department, sales@attana.com.

About Attana:

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. www.attana.com/about-us/attana-movie-2015/